VAERS Reports GS3275

VAERS 2682150

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Gs3275

gering

Staat: VA
Alter: 69,0
Geschlecht: F
Eingang: 14.09.2023
Impfdatum: 28.04.2023
Beginn: -
Tage bis Beginn: -
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

COVID-19 treatment; COVID-19 treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 70-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Apr2023 as dose 5 (booster), single (Lot number: Gs3275) at the age of 69 years for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Type 1 diabetes" (unspecified if ongoing), notes: Other medical history: Type 1 diabetes. The patient's concomitant medications were not reported. Past drug history included: Compazine, reaction(s): "Known allergies: Compazine". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19 treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Treatment of COVID-19; (Sep2023) negative, notes: I had two negative test 48 hours apart; (Sep2023) negative, notes: I had two negative test 48 hours apart; (Sep2023) positive, notes: I tested positive. Therapeutic measures were taken as a result of drug ineffective and covid-19 with paxlovid from 31Aug2023 to 05Sep2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Name: COVID-19 Test; Test Result: Positive ; Comments: Treatment of COVID-19; Test Date: 202309; Test Name: COVID-19 Test; Test Result: Negative ; Comments: I had two negative test 48 hours apart; Test Date: 202309; Test Name: COVID-19 Test; Test Result: Negative ; Comments: I had two negative test 48 hours apart; Test Date: 202309; Test Name: COVID-19 Test; Test Result: Positive ; Comments: I tested positive.
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Type 1 diabetes mellitus (Other medical history: Type 1 diabetes)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2657960

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GS3275

gering

Staat: TX
Alter: 52,0
Geschlecht: F
Eingang: 19.07.2023
Impfdatum: 27.10.2022
Beginn: 01.06.2023
Tage bis Beginn: 217,0
Dosis: 5
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective

Symptomtext

Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 53-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 27Oct2022 at 17:00 as dose 5 (booster), single (Lot number: GS3275) at the age of 52 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 19Jan2021 at 15:30 as dose 1, single (Lot number: EL9261), in left arm, on 08Feb2021 at 09:30 as dose 2, single (Lot number: EM9810), in left arm, on 07Oct2021 at 16:00 as dose 3 (booster), single (Lot number: FF8839), in left arm and on 11Jun2022 at 11:30 as dose 4 (booster), single (Lot number: FM0173), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Tachycardia" (unspecified if ongoing); "massive bilateral pulmonary emboli" (unspecified if ongoing); "DVT from knee trauma, skiing" (unspecified if ongoing); "Allergic rhinitis" (unspecified if ongoing); "migraine (rare)" (unspecified if ongoing); "PENICILLINS ALLERGY" (unspecified if ongoing); "knee trauma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jun2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient received COVID 19 Treatment as Paxlovid with start date 30Jun2023 and stop date 05Jul2023.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300122487 same reporter/patient, different product/AE;

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Allergic rhinitis; DVT; Knee injury; Migraine; Penicillin allergy; Pulmonary embolism; Tachycardia
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626023

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GS3275

gering

Staat: CA
Alter: 46,0
Geschlecht: F
Eingang: 03.05.2023
Impfdatum: 15.11.2022
Beginn: 01.04.2023
Tage bis Beginn: 137,0
Dosis: 4
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective

Symptomtext

Drug ineffective; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 46-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 15Nov2022 at 12:00 as dose 4 (booster), single (Lot number: GS3275) at the age of 46 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Autoimmune disorders" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: COVID-19 (medically significant) with onset Apr2023, outcome "unknown"; DRUG INEFFECTIVE (medically significant) with onset Apr2023, outcome "unknown". Therapeutic measures were taken as a result of Drug ineffective, Covid-19 which includes Paxlovid treatment from 17Apr2023 to 21Apr2023. Clinical course: It was unknown if the patient had other medication in 2 weeks. The patient had no known allergies. Took and completed 5 days of Paxlovid on day 3 of Covid 19 symptoms.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300175652 same patient/reporter, different drug/event;

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Autoimmune disorder
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -